Skip to main content
OpenTrials
Completed

NCT Number: NCT05681338

Effect of the Coughing Technique During Subcutaneous Heparin Injection

Objective: to examine the effect of the medium intensity coughing technique during subcutaneous low molecular weight heparin injection on pain severity and individual satisfaction in general surgery patients. Method: a prospective, quasi-experimental study included 100 patients who had prescribed a subcutaneous low molecular weight heparin injection once in 24 hours. Each patient received two injections by the same researcher using standard injection technique with medium intensity coughing technique and only standard injection technique.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Thyroidectomy Cholecystectomy Colon Surgery Hernia Hernia, Abdominal Hernia, Inguinal Inguinal Hernia Neurologic Manifestations Pain Pathological Conditions, Anatomical Pathological Conditions, Signs and Symptoms Signs and Symptoms

Age range

22 year–86 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Bursa Uludag University Hospital

Bursa, Nilüfer, 16059, Turkey (Türkiye)

About this study

Aims and objectives: The aim of this study was to examine the effect on the level of pain severity and satisfaction of patients of the medium intensity coughing technique applied to patients during the administration of subcutaneous low molecular weight heparin (LMWH) injection.

Design: This research was a prospective quasi-experimental study. Methods: It was conducted with 100 patients in the General Surgery Clinic of a university hospital in the Marmara Region of Turkey. Subcutaneous LMWH injections were administered by the same nurse to the outer side of the right and left upper arms by the standard injection technique and the medium intensity coughing technique. Immediately after the subcutaneous LMWH injection was given, a researcher who did not know which injection method had been used asked the patients to evaluate their pain levels by the Visual Analog Scale (VAS) and their satisfaction with the performance of the injection by the Visual Individual Satisfaction Scale (VISS).

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Participating voluntarily in the study
  • Being over the age of 18,
  • Having a doctor's prescription for subcutaneous low molecular weight heparin 0.6 mL treatment and not yet having begun treatment.
  • Having no coagulation disorder, having no disorder that could affect pain perception, -
  • Having no incision, lipodystrophy, or finding of infection at the injection site,
  • Having no communication problem

Exclusion criteria

  • Not wanting to participate in the study, or during the course of the research, wishing to withdraw from the study
  • Having any condition which would affect the sensation of pain
  • Not being able to agree on a place or time
  • Being less than 18 years of age

Treatment and study plan

the medium intensity coughing technique

Other

The medium intensity coughing technique: Immediately before the subcutaneous LMWH injection was given, patients were asked to cough twice at a medium level. After that, they were asked to cough ten seconds later for a second time at the same level, and while they were coughing for the second time, the needle was inserted into the tissue.

Primary outcomes

  1. Pain assessed by Visual Analog Scale (VAS)

    Time frame: 2 months

    In evaluating the severity of pain felt by the patients during subcutaneous injections, a 10 cm long vertical VAS was used, on which one end represented no pain, and the other end the worst possible pain. The VAS is a commonly used pain assessment scale in clinical settings. Pain severity measurements were evaluated in millimeters.

  2. "Satisfaction assessed by the Visual Individual Satisfaction Scale (VISS)

    Time frame: 2 months

    During the administration of the injection, an evaluation was made to determine individuals' satisfaction using the Visual Individual Satisfaction Scale, which consisted of a vertical 10 cm scale with "I'm very satisfied" written at one end of it and "I'm not at all satisfied" at the other. The Visual Individual Satisfaction Scale incorporated the characteristics of the well-known Visual Analog Scale (VAS). Satisfaction level measurements were evaluated in millimeters.

Secondary outcomes

  1. Weight

    Time frame: 2 months

    weight in kilograms

  2. Height

    Time frame: 2 months

    height in meters

  3. BMI

    Time frame: 2 months

    BMI in kg/m^2

Sponsors and collaborators

Lead sponsor

Uludag University

Other

Registry information

Official study title

Effect of the Coughing Technique During Subcutaneous Heparin Injection on Pain Severity and Individual Satisfaction

Important dates

Study start
2022
Primary completion
2022
Study completion
2022
First posted
Jan 12, 2023
Registry last updated
Mar 6, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.